Concepedia

Diwakar Davar

DD

41

Publications

4K

Citations

23

H-Index

2011

Active since

Affiliations

UPMC Hillman Cancer Center(Current)

University of Pittsburgh Medical Center

University of Pittsburgh

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Diwakar Davar is an author at UPMC Hillman Cancer Center specializing in immunology, medicine, and tumor immunity.

Top concepts

MedicineImmunologyOncologyTumor ImmunityImmunotherapyRadiation OncologyCancer TherapyCancer ResearchPathologyImmuno-oncology

Publications per year

2011–2025

41

Publications

41

Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

Diwakar Davar, Amiran Dzutsev, John A. McCulloch et al. · Science · 2021 · 1.4K citations · Full text

Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment

Mackenzie Bender, Alex McPherson, Catherine M. Phelps et al. · Cell · 2023 · 567 citations · Full text

Probiotic, Dysbiosis, Medicine +7

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Michael B. Atkins, Sandra J. Lee, Bartosz Chmielowski et al. · Journal of Clinical Oncology · 2022 · 402 citations · Full text

CD226 opposes TIGIT to disrupt Tregs in melanoma

Julien Fourcade, Zhaojun Sun, Joë-Marc Chauvin et al. · JCI Insight · 2018 · 195 citations · Full text

T-regulatory Cell, Immune Regulation, Immunology +16

IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma

Joë-Marc Chauvin, Mignane Ka, Ornella Pagliano et al. · Clinical Cancer Research · 2020 · 143 citations · Full text

Rows per page

1–5 of 41